Viral Infections of Humans - Taschenbuch

EAN (ISBN-13): 9781461332398
ISBN (ISBN-10): 1461332397
Taschenbuch
Erscheinungsjahr: 2011
Herausgeber: Springer-Verlag New York Inc.

Buch in der Datenbank seit 2013-12-16T11:29:47+01:00 (Berlin)
Detailseite zuletzt geändert am 2023-12-20T00:01:43+01:00 (Berlin)
ISBN/EAN: 9781461332398

ISBN - alternative Schreibweisen:
1-4613-3239-7, 978-1-4613-3239-8
Alternative Schreibweisen und verwandte Suchbegriffe:
Autor des Buches: clar winter, evans
Titel des Buches: viral infections epidemiology control

---

Daten vom Verlag:

Autor/in: Alfred S. Evans
Titel: Viral Infections of Humans - Epidemiology and Control
Verlag: Springer; Springer US
720 Seiten
Erscheinungsjahr: 2011-11-01
New York; NY; US
Gedruckt / Hergestellt in Niederlande.
Gewicht: 1,429 kg
Sprache: Englisch
106,99 € (DE)
109,99 € (AT)
118,00 CHF (CH)
POD
XXXVIII, 720 p.

BC; Internal Medicine; Hardcover, Softcover / Medizin/Klinische Fächer; Klinische und Innere Medizin; Verstehen; Hepatitis; Malaria; antigen; arbovirus; arenaviruses; epidemiology; infection; infections; nutrition; pathogenesis; prevention; vaccination; vaccine; viral infection; virus; Internal Medicine; BB

I. Introduction and Concepts.- l Epidemiological Concepts and Methods.- 1. Introduction.- 2. Definitions and Methods.- 3. Epidemics.- 4. Investigation of an Epidemic.- 5. The Agent.- 6. The Environment.- 7. The Host.- 8. Routes of Transmission.- 8.1. Respiratory.- 8.2. Gastrointestinal.- 8.3. Skin.- 8.4. Genital.- 8.5. Intrauterine or Transplacental.- 8.6. Genitourinary.- 8.7. Personal Contact.- 8.8. Water and Food.- 8.9. Arthropod-Borne.- 9. Pathogenesis.- 9.1. Respiratory.- 9.2. Gastrointestinal.- 9.3. Systemic Infections.- 9.4. The Exanthem.- 9.5. Infections of the Central Nervous System.- 9.6. Persistent Viral Infections.- 10. Incubation Period.- 11. The Immune Response.- 11.1. Humoral Immunity.- 11.2. Local Immunity (Secretory IgA System).- 11.3. Cell-Mediated Immunity.- 11.4. Immune Responses in the Pathogenesis of Viral Diseases.- 12. Patterns of Host Responses.- 12.1. The Biological Gradient.- 12.2. Clinical Syndromes.- 13. Diagnosis of Viral Diseases.- 13.1. Collection.- 13.2. Requests for Testing.- 13.3. Tests Employed.- 13.4. Interpretation of Tests.- 14. Proof of Causation.- 15. Control and Prevention.- 15.1. Immunization.- 15.2. Chemoprophylaxis and Therapy.- 16. References.- 17. Suggested Reading.- 2 Surveillance and Seroepidemiology.- 1. Introduction.- 2. Surveillance.- 2.1. Historical Background.- 2.2. Elements of Surveillance.- 2.3. Other Surveillance Methods.- 2.4. Surveillance in Research Studies.- 2.5. Publications on Surveillance.- 2.6. Predictive Surveillance.- 3 Seroepidemiology.- 3.1. Introduction.- 3.2. Historical Background.- 3.3. Methodology.- 3.4. Advantages and Limitations.- 3.5. Uses of Seroepidemiology.- 4. References.- II. Acute Viral Infections.- 3 Adenoviruses.- 1. Introduction.- 2. Historical Background.- 3. Methodology Involved in Epidemiological Analysis.- 3.1. Sources of Data.- 3.2. Interpretation of Laboratory Tests.- 4. Characteristics of the Virus.- 5. Descriptive Epidemiology.- 5.1. Synopsis of Descriptive Epidemiology.- 5.2. Epidemiological and Clinical Aspects of Specific Syndromes.- 6. Mechanisms and Route of Transmission.- 7. Pathogenesis and Immunity.- 8. Patterns of Host Response.- 9. Control and Prevention.- 10. Unresolved Problems.- 11. References.- 12. Suggested Reading.- 4 African Hemorrhagic Fevers Due to Marburg and Ebola Viruses.- 1. Introduction.- 2. Historical Background.- 3. Methodology Used in Epidemiological Analysis.- 3.1. Sources of Morbidity and Mortality Data.- 3.2. Laboratory Diagnosis.- 3.3. Surveys.- 3.4. Clinical Diagnosis of Acute Infection.- 4. Characteristics of Marburg and Ebola Viruses.- 4.1. Morphology and Morphogenesis.- 4.2. Physical Properties.- 4.3. Chemical Properties.- 4.4. Biological Properties.- 4.5. Serological Relationships.- 5. Descriptive Epidemiology.- 5.1. Prevalence and Incidence.- 5.2. Epidemic Behavior and Contagiousness.- 5.3. Other Epidemiological Features.- 6. Mechanism and Route of Transmission.- 6.1. Spread of Virus.- 6.2. Reservoir.- 7. Pathogenesis and Immunity.- 7.1. In Guinea Pigs and Hamsters.- 7.2. In Nonhuman Primates.- 7.3. In Man.- 8. Patterns of Host Response.- 8.1. Clinical Features.- 8.2. Diagnosis.- 9. Prevention and Control.- 9.1. General Concepts.- 9.2. Management and Disposition of Patients.- 9.3. General Strategy for Isolation and Management of Suspect “Exotic” Infections.- 10. Unresolved Problems: Detection of Infection and Disease.- 11. References.- 12. Suggested Reading.- 5 Arboviruses.- 1. Introduction.- 2. Historical Background.- 3. Methodology Involved in Epidemiolgical Analysis.- 3.1. Sources of Mortality Data.- 3.2. Sources of Morbidity Data.- 3.3. Serological Surveys.- 3.4. Laboratory Methods.- 4. Biological Charactristics of the Virus That Affect the Epidemiological Pattern.- 5. Epidemiology.- 5.1. Incidence and Prevalence.- 5.2. Epidemic Behavior.- 5.3. Geographic Distribution.- 5.4. Temporal Distribution.- 5.5. Age and Sex.- 5.6. Other Factors.- 6. Mechanism and Route of Transmission.- 7. Pathogenesis and Immunity.- 8. Patterns of Host Response.- 8.1. Clinical Features.- 8.2. Diagnosis.- 9. Control and Prevention.- 10. Characteristics of Selected Arboviruses.- 10.1. Arboviruses of Importance in the United States.- 10.2. Other Arboviruses in the United States That Affect Human Beings.- 10.3. Arboviruses Outside the United States That Affect Human Beings.- 11. Unresolved Problems.- 11.1. The Viruses.- 11.2. The Vectors.- 11.3. The Vertebrate Hosts.- 11.4. Transmission Cycles Involving Virus, Vector, and Vertebrate.- 11.5. Disease in the Vertebrate Host.- 11.6. Control.- 12. References.- 13. Suggested Reading.- 6 Arenaviruses.- 1. Introduction.- 2. Historical Background.- 3. Methodology.- 3.1. Mortality.- 3.2. Morbidity.- 3.3. Serological Surveys.- 3.4. Laboratory Diagnosis.- 4. The Viruses.- 4.1. Biochemical and Physical Properties.- 4.2. Morphology and Morphogenesis.- 4.3. Antigenic Properties.- 4.4. Biological Properties.- 5. Pathogenesis and Immunity.- 6. Lymphocytic Choriomeningitis.- 6.1. Descriptive Epidemiology.- 6.2. Mechanism and Route of Transmission.- 6.3. Patterns of Host Response.- 6.4. Treatment and Prevention.- 7. Argentinian Hemorrhagic Fever.- 7.1. Descriptive Epidemiology.- 7.2. Mechanism and Route of Transmission.- 7.3. Patterns of Host Response.- 7.4. Treatment, Control, and Prevention.- 8. Bolivian Hemorrhagic Fever.- 8.1. Descriptive Epidemiology.- 8.2. Mechanism and Route of Transmission.- 8.3. Patterns of Host Response.- 8.4. Treatment, Prevention, and Control.- 9. Lassa Fever.- 9.1. Descriptive Epidemiology.- 9.2. Mechanism and Route of Transmission.- 9.3. Patterns of Host Response.- 9.4. Treatment and Disposition of Patients.- 9.5. Prevention and Control.- 10. Hemorrhagic Fever with Renal Syndrome.- 11. Unresolved Questions.- 11.1. Vaccines.- 11.2. Serum Therapy.- 11.3. Immunopathology.- 11.4. Geographic Distribution.- 12. References.- 13. Suggested Reading.- 7 Coronaviruses.- 1. Introduction.- 2. Historical Background.- 3. Methodology.- 3.1. Sources of Mortality Data.- 3.2. Sources of Morbidity Data.- 3.3. Serological Surveys.- 3.4. Laboratory Methods.- 4. Biological Characteristics of the Virus.- 5. Descriptive Epidemiology.- 5.1. Incidence and Prevalence.- 5.2. Geographic Distribution.- 5.3. Temporal Distribution.- 5.4. Age.- 5.5. Other Factors.- 6. Mechanisms and Routes of Transmission.- 7. Pathogenesis and Immunity.- 8. Patterns of Host Response.- 9. Control and Prevention.- 10. Unresolved Problems.- 11. References.- 12. Suggested Reading.- 8 Cytomegalovirus.- 1. Introduction.- 2. Historical Background.- 3. Methodology.- 3.1. Mortality.- 3.2. Morbidity.- 3.3. Serological Surveys.- 3.4. Laboratory Diagnosis.- 4. Biological Characteristics of the Virus.- 5. Descriptive Epidemiology.- 5.1. Prevalence and Incidence.- 5.2. Geographic Distribution.- 5.3. Age and Sex.- 5.4. Temporal Distribution.- 5.5. Occupation.- 5.6. Race and Socioeconomic Setting.- 6. Mechanism of Transmission.- 7. Pathogenesis and Immunity.- 7.1. Pathogenesis.- 7.2. Immunity.- 8. Patterns of Host Response.- 8.1. Neonatal Infections.- 8.2. Infection of Children and Adults.- 9. Immunization.- 10. Unresolved Problems.- 11. References.- 12. Suggested Reading.- 9 Enteroviruses.- 1. Introduction.- 2. Historical Background.- 3. Methodology Involved in Epidemiological Analysis.- 3.1. Sources of Mortality Data.- 3.2. Sources of Mobidity Data.- 3.3. Serological and Clinical Surveys.- 3.4. Virus Isolation from Surface Waters as an Indicator of Community Infections.- 3.5. Laboratory Methods.- 4. Biological Characteristics of the Virus That Affect the Epidemiological Pattern.- 4.1. General Properties.- 4.2. Reactions to Chemical and Physical Agents.- 4.3. Antigenic Characteristics.- 4.4. Host Range in Vivo and in Vitro.- 4.5. Replication of Enteroviruses.- 5. Descriptive Epidemiology.- 5.1. General Epidemiology of Enteroviruses.- 5.2. Epidemiological Patterns of Poliomyelitis.- 6. Mechanisms and Route of Transmission.- 7. Pathogenesis and Immunity.- 7.1. Pathogenesis.- 7.2. Immunity.- 8. Patterns of Host Response and Diagnosis.- 8.1. Clinical Syndromes.- 8.2. Diagnosis.- 9. Control and Prevention of Poliomyelitis.- 9.1. Killed Polio Vaccine.- 9.2. Live Attenuated Polio Vaccine.- 9.3. Conclusions on Polio Vaccines and Their Future Use.- 9.4. Current Status of Immunity against Poliomyelitis in the United States.- 9.5. “Social Failures” of Polio Vaccine Administration.- 9.6. Nonspecific Control Measures for Poliomyelitis.- 10. Control of Other Enterovirus Infections.- 11. Control of Enteroviruses in Water.- 12. Unresolved Problems.- 13. References.- 14. Suggested Reading.- 10 Epstein-Barr Virus.- 1. Introduction.- 2. Historical Background.- 3. Methodology.- 3.1. Mortality Data.- 3.2. Morbidity Data.- 3.3. Serological Surveys.- 3.4. Laboratory Methods.- 4. Biological Characteristics of the Agent.- 4.1. The Virus.- 4.2. Proof of Causation of Infectious Mononucleosis.- 5. Descriptive Epidemiology.- 5.1. Prevalence and Incidence.- 5.2. Epidemic Behavior.- 5.3. Geographic Distribution.- 5.4. Temporal Distribution.- 5.5. Age.- 5.6. Sex.- 5.7. Race.- 5.8. Occupation.- 5.9. Occurence in Different Settings.- 5.10. Socioeconomic Factors.- 5.11. Other Factors.- 6. Mechanism and Route of Transmission.- 7. Pathogenesis and Immunity.- 8. Patterns of Host Response.- 8.1. Clinical Features.- 8.2. Diagnosis.- 9. Control and Prevention.- 10. Unsolved Problems.- 11. References.- 12. Suggested Reading.- 11 Viral Gastroenteritis.- 1. Introduction.- 2. Historical Background.- 3. Methodology Involved in Epidemiological Analysis.- 3.1. Sources of Mortality Data.- 3.2. Sources of Morbidity Data.- 3.3. Serological Surveys.- 3.4. Laboratory Methods.- 4. Biological Characteristics.- 4.1. Norwalk Group of Viruses.- 4.2. Rotaviruses.- 5. Descriptive Epidemiology.- 5.1. Norwalk Group of Viruses.- 5.2. Rotaviruses.- 6. Mechanisms and Route of Transmission.- 6.1. Norwalk Group of Viruses.- 6.2. Rotaviruses.- 7. Pathogenesis and Immunity.- 7.1. Norwalk Group of Viruses.- 7.2. Rotaviruses.- 8. Patterns of Host Response.- 8.1. Norwalk Group of Viruses.- 8.2. Rotaviruses.- 9. Control and Prevention.- 9.1. Norwalk Group of Viruses.- 9.2. Rotaviruses.- 10. Unresolved Problems.- 10.1. Norwalk Group and Miscellaneous Enteric Agents.- 10.2. Rotaviruses.- 11. References.- 12. Suggested Reading.- 12 Viral Hepatitis.- 1. Introduction.- 2. Historical Background.- 3. Methodology Involved in Epidemiological Analysis.- 3.1. Mortality.- 3.2. Morbidity.- 3.3. Serological Surveys.- 3.4. Laboratory Methods.- 4. Biological Characteristics of the Human Hepatitis Viruses.- 4.1. Hepatitis A Virus.- 4.2. Hepatitis B Virus.- 4.3. Non-A, Non-B Hepatitis Viruses.- 5. Descriptive Epidemiology.- 5.1. Viral Hepatitis A.- 5.2. Viral Hepatitis B.- 5.3. Non-A, Non-B Viral Hepatitis.- 6. Mechanisms and Routes of Transmission.- 6.1. Viral Hepatitis A.- 6.2. Viral Hepatitis B.- 6.3. Non-A, Non-B Viral Hepatitis.- 7. Pathogenesis and Immunity.- 7.1. Viral Hepatitis A.- 7.2. Viral Hepatitis B.- 7.3. Non-A, Non-B Viral Hepatitis.- 8. Patterns of Host Response.- 8.1. Clinical Features.- 8.2. Primary Hepatocellular Carcinoma.- 8.3. Laboratory Diagnosis.- 9. Control and Prevention.- 9.1. Viral Hepatitis A.- 9.2. Viral Hepatitis B.- 9.3. Non-A, Non-B Viral Hepatitis.- 10. Unresolved Problems.- 11. References.- 12. Suggested Reading.- 13 Herpes Simplex Viruses 1 and 2.- 1. Introduction and Social Aspects.- 2. Evolutionary and Historical Background.- 3. Methodology Involved in Epidemiological Analysis.- 3.1. Mortality.- 3.2. Morbidity.- 3.3. Serological Surveys.- 3.4. Laboratory Diagnosis.- 4. Biological Characteristics of Herpes Simplex Viruses 1 and 2.- 5. Descriptive Epidemiology.- 5.1. General Epidemiology.- 5.2. Epidemiological Aspects of Specific Clinical Entities.- 6. Mechanisms and Routes of Transmission.- 7. Pathogenesis and Immunity.- 8. Patterns of Host Response.- 8.1. Mouth and Respiratory and Gastrointestinal Tracts.- 8.2. Lips.- 8.3. Eyes.- 8.4. Skin.- 8.5. Urogenital tract.- 8.6. Nervous System.- 8.7. Fetus and Newborn.- 9. Control and Prevention.- 9.1. Prevention of the Initial Infection.- 9.2. Reduction of the Source of Virus Transmissible to Others.- 10. Unresolved Problems.- 10.1. Reporting.- 10.2. Virological Aspects.- 10.3. Host Factors.- 10.4. Control and Prevention.- 11. References.- 12. Suggested Reading.- 14 Influenza Viruses.- 1. Introduction.- 2. Historical Background.- 3. Epidemiological Methodology.- 3.1. Mortality Data.- 3.2. Morbidity Data.- 3.3. Serological Surveys.- 3.4. Laboratory Methods.- 4. Biological Characteristics of the Virus.- 5. Descriptive Epidemiology.- 5.1. Incidence and Prevalence Data.- 5.2. Epidemic Behavior.- 5.3. Geographic Distribution.- 5.4. Temporal Distribution.- 5.5. Age.- 5.6. Other Factors.- 6. Transmission.- 7. Pathogenesis and Immunity.- 7.1. Pathogenesis..- 7.2. Immunity.- 8. Patterns of Host Response.- 8.1. Clinical Features.- 8.2. Diagnosis.- 9. Control Measures.- 10. Unresolved Problems..- 11. References.- 12. Suggested Reading.- 15 Measles.- 1. Introduction.- 2. Historical Background.- 3. Methodology Involved in Epidemiological Analysis.- 3.1. Sources of Mortality Data.- 3.2. Sources of Morbidity Data.- 3.3. Serological Surveys.- 3.4. Laboratory Methods.- 4. Biological Characteristics of the Virus.- 5. Descriptive Epidemiology.- 5.1. Incidence.- 5.2. Epidemic Behavior.- 5.3. Geographic Distribution.- 5.4. Temporal Distribution.- 5.5. Age.- 5.6. Sex.- 5.7. Race.- 5.8. Occupation.- 5.9. Social Setting.- 5.10. Socioeconomic Status.- 5.11. Nutrition.- 6. Transmission.- 7. Pathogenesis and Immunity.- 8. Patterns of Host Response.- 8.1. Clinical Features of Unusual Forms.- 8.2. Diagnosis.- 9. Control and Prevention.- 10. Unresolved Problems.- 10.1. Vaccine Distribution in Developing Countries.- 10.2. Eradication.- 10.3. Measles and Multiple Sclerosis.- 11. References.- 16 Mumps.- 1. Introduction.- 2. Historical Background.- 3. The Agent.- 4. Methodology Involved in Epidemiological Analysis.- 4.1. Sources of Data.- 4.2. Serological Surveys.- 4.3. Laboratory Methods.- 5. Descriptive Epidemiology.- 5.1. Incidence and Prevalence.- 5.2. Survey Data.- 5.3. Epidemic Behavior and Contagiousness.- 5.4. Geographic Distribution.- 5.5. Temporal Distribution.- 5.6. Age.- 5.7. Sex.- 5.8. Race and Occupation.- 5.9. Occurrence in Different Settings.- 5.10. Other Factors.- 6. Mechanisms and Routes of Transmission.- 7. Pathogenesis and Immunity.- 8. Patterns of Host Response.- 8.1. Common Clinical Features.- 8.2. Involvement of the Central Nervous System.- 8.3. Involvement of the Heart.- 8.4. Orchitis and Sterility.- 8.5. Mumps and Diabetes.- 8.6. Other Complications.- 9. Control and Prevention.- 10. Unresolved Problems.- 11. References.- 12. Suggested Reading.- 17 Parainfluenza Viruses.- 1. Introduction.- 2. Historical Background.- 3. Methodology Involved in Epidemiological Analysis.- 3.1. Sources of Mortality Data.- 3.2. Sources of Morbidity Data.- 3.3. Serological Surveys.- 3.4. Laboratory Methods.- 4. Biological Characteristics of the Virus That Affect the Epidemiological Pattern.- 5. Descriptive Epidemiology.- 5.1. Incidence and Prevalence Data.- 5.2. Epidemic Behavior.- 5.3. Geographic Distribution.- 5.4. Temporal Distribution.- 5.5. Age Distribution.- 5.6. Sex.- 5.7. Race and Occupation.- 5.8. Occurrence in Special Epidemiological Settings.- 5.9. Socioeconomic Status.- 6. Mechanisms and Routes of Transmission.- 7. Pathogenesis and Immunity.- 7.1. Pathogenesis.- 7.2. Immunity.- 8. Patterns of Host Response.- 8.1. Clinical Manifestations.- 8.2. Diagnosis.- 9. Control and Prevention Based on Epidemiological Data.- 10. Unresolved Problems.- 11. References.- 12. Suggested Reading.- 18 Rabies.- 1. Introduction.- 2. Historical Background.- 3. Methodology Involved in Epidemiological Analysis.- 3.1. Sources of Mortality Data.- 3.2. Sources of Morbidity Data.- 3.3. Serological Surveys.- 3.4. Laboratory Methods.- 4. Biological Characteristics of the Virus That Affect the Epidemiological Pattern.- 5. Descriptive Epidemiology.- 5.1. Incidence.- 5.2. Epidemic Behavior.- 5.3. Geographic Distribution.- 5.4. Temporal Distribution.- 5.5. Age, Sex, Race, Occupation, Socioeconomic, Nutritional and Genetic Factors.- 6. Mechanisms and Route of Transmission.- 7. Pathogenesis and Immunity.- 8. Patterns of Host Response.- 8.1. Clinical Features.- 8.2. Diagnosis.- 9. Control and Prevention.- 9.1. Epidemiological Methods.- 9.2. Immunization Concepts and Practice.- 10. Unresolved Problems.- 10.1. Epizootiology of Wildlife Rabies.- 10.2. Rabies-Related Viruses.- 10.3. Vaccines.- 10.4. Pathogenesis and Virulence.- 11. References.- 12. Suggested Reading.- 19 Respiratory Syncytial Virus.- 1. Introduction and Historical Background.- 2. Methodology Involved in Epidemiological Analysis.- 2.1. Sources of Mortality Data.- 2.2. Sources of Morbidity Data.- 2.3. Serological Surveys.- 2.4. Laboratory Methods.- 3. Biological Characteristics of the Virus That Affect the Epidemiological Pattern.- 4. Descriptive Epidemiology.- 4.1. Incidence and Prevalence Data.- 4.2. Epidemic Behavior.- 4.3. Geographic Distribution.- 4.4. Temporal Distribution.- 4.5. Age.- 4.6. Sex.- 4.7. Race.- 4.8. Occupation.- 4.9. Occurrence in Different Settings.- 4.10. Socioeconomic Status.- 4.11. Other Factors.- 5. Mechanisms and Routes of Transmission.- 6. Pathogenesis and Immunity.- 7. Patterns of Host Response.- 7.1. Symptoms.- 7.2. Diagnosis.- 8. Control and Prevention.- 9. Unresolved Problems.- 10. References.- 20 Rhinoviruses.- 1. Introduction.- 2. Historical Background.- 3. Methodology Involved in Epidemiological Analysis.- 3.1. Surveillance and Sampling.- 3.2. Methods of Virus Isolation and Propagation.- 3.3. Methods Used for Serological Surveys and Antibody Measurements.- 4. Characteristics of the Virus That Affect the Epidemiological Pattern.- 4.1. Physical and Biochemical Characteristics.- 4.2. Biological Characteristics.- 4.3. Antigenic Characteristics.- 5. Descriptive Epidemiology.- 5.1. Incidence and Prevalence of Infection.- 5.2. Occurrence in Different Settings.- 6. Mechanisms and Routes of Transmission.- 7. Pathogenesis.- 8. Immunity.- 9. Patterns of Host Response.- 9.1. Clinical Features.- 9.2. Apparent/Inapparent Infection Ratios.- 10. Control and Prevention.- 11. Unresolved Problems.- 12. References.- 13. Suggested Reading.- 21 Rubella.- 1. Introduction.- 2. Historical Background.- 3. Methodology.- 3.1. Mortality Data.- 3.2. Morbidity Data.- 3.3. Serological Surveys.- 3.4. Laboratory Methods.- 4. Biological Characteristics of the Virus.- 5. Descriptive Epidemiology.- 5.1. Incidence and Prevalence.- 5.2. Epidemic Behavior.- 5.3. Geographic Distribution.- 5.4. Temporal Distribution.- 5.5. Age and Sex.- 5.6. Other Factors.- 6. Mechanisms and Routes of Transmission.- 7. Pathogenesis and Immunity.- 8. Patterns of Host Response.- 8.1. Clinical Manifestations.- 8.2. Serological Responses.- 9. Control.- 9.1. Vaccine Development.- 9.2. Responses to Rubella Vaccines.- 9.3. Vaccination of Children: Impact on Rubella Incidence.- 9.4. Vaccination of Women of Childbearing Age.- 9.5. Management of the Rubella Problem in Pregnancy.- 9.6. Use of Immune Serum Globulin.- 10. Unresolved Problems.- 11. References.- 12. Suggested Reading.- 22 Smallpox.- 1. Introduction.- 2. Historical Background.- 3. Methodology Involved in Epidemiological Analysis.- 3.1. Sources of Mortality Data.- 3.2. Sources of Morbidity Data.- 3.3. Surveys.- 3.4. Laboratory Methods.- 4. Biological Characterisitics of the Virus.- 5. Descriptive Epidemiology.- 5.1. Incidence and Prevalence Data.- 5.2. Epidemic Behavior.- 5.3. Geographic Distribution.- 5.4. Temporal Distribution.- 5.5. Age.- 5.6. Sex.- 5.7. Race.- 5.8. Occupation.- 5.9. Occurrence in Different Settings.- 5.10. Socioeconomic Status.- 5.11. Other Factors.- 6. Mechanisms and Routes of Transmission.- 6.1. Period of Communicability.- 6.2. Contact Spread.- 6.3. Airborne Spread.- 6.4. Spread by Fomites.- 6.5. Vectors.- 6.6. Animal Reservoirs.- 7. Pathogenesis and Immunity.- 7.1. Pathogenesis.- 7.2. Immunity.- 8. Patterns of Host Response.- 9. Control and Prevention Based on Epidemiological Data.- 9.1. Control Program.- 9.2. Immunization Concepts and Practice.- 9.3. Success of the Program.- 9.4. Plans for the Future.- 10. Unresolved Problems.- 11. References.- 12. Suggested Reading.- 23 Varicella-Herpes Zoster Virus.- 1. Introduction.- 1.1. Definition.- 1.2. Social Significance.- 2. Historical Background.- 2.1. Clinical Recognition.- 2.2. Association of Varicella with Herpes Zoster.- 2.3. Isolation and Propagation of the Etiological Agent of Varicella-Zoster.- 3. Methodology Involved in Epidemiological Analysis.- 3.1. Sources of Mortality Data.- 3.2. Sources of Morbidity Data.- 3.3. Serological Surveys.- 3.4. Laboratory Methods.- 4. Biological Characteristics of the Virus That Affect the Epidemiological Pattern.- 4.1. Latency in the Human Host: Primary Infection, Latency, and Reactivation.- 4.2. Failure of Varicella-Zoster Virus to Persist in Scabs or Fomites: Limited Period of Communicability.- 5. Descriptive Epidemiology.- 5.1. Incidence and Prevalence Data.- 5.2. Epidemic Behavior.- 5.3. Geographic Distribution.- 5.4. Temporal Distribution.- 5.5. Age.- 5.6. Sex.- 5.7. Race.- 5.8. Occupation.- 5.9. Occurrence of Varicella in Different Settings.- 5.10. Socioeconomic Status.- 5.11. Other Factors.- 6. Mechanisms and Routes of Transmission.- 6.1. Varicella.- 6.2. Herpes Zoster.- 7. Pathogenesis and Immunity.- 7.1. Varicella.- 7.2. Herpes Zoster.- 8. Patterns of Host Response.- 8.1. Clinical Patterns.- 8.2. Diagnosis.- 9. Control and Prevention.- 9.1. General Concepts.- 9.2. Interruption of Transmission.- 9.3. Modification or Prevention of Varicella.- 10. Unresolved Problems.- 10.1. Prevention.- 10.2. Pathogenesis.- 10.3. Epidemiological Unknowns.- 11. References.- 12. Suggested Reading.- 12.1. Monographic Summaries of Information on Varicella and on Herpes Zoster.- 12.2. Comprehensive Review of the Epidemiology of Varicella, with 257 References Covering the Literature through 1961.- 12.3. Summary of Procedures for Isolation and Study of Varicella-Zoster Virus in the Laboratory.- 12.4. Clinical Descriptions of Varicella and of Zoster, Including Complications and Differential Diagnosis.- 12.5. An Encyclopedic, Multiauthored Summary of Knowledge of the Herpesviruses of Man and of Animals.- III. Malignant and Chronic Neurological Diseases Associated WithViruses.- 24 Burkitt Lymphoma.- 1. Introduction.- 2. Historical Background.- 3. Methodology.- 3.1. Mortality and Morbidity Data.- 3.2. Serological Surveys.- 3.3. Laboratory Diagnosis.- 4. Biology of Epstein-Barr Virus.- 4.1. Structure and Morphology.- 4.2. Epstein-Barr Virus Cell-Associated Antigens.- 4.3. Cell-Virus Relationships.- 4.4. Cell Transformation and Oncogenicity.- 4.5. Relationship of Epstein-Barr Virus to Burkitt Lymphoma.- 5. Descriptive Epidemiology.- 5.1. Incidence.- 5.2. Geographic Factors.- 5.3. Age and Sex.- 5.4. Genetic and Other Host Factors.- 6. Mechanism and Route of Transmisson.- 7. Pathogenesis.- 7.1. Cell Transformation.- 7.2. Immunological Surveillance.- 8. Patterns of Host Response.- 8.1. Clinical and Pathological Features.- 8.2. Serological Features.- 9. Therapy and Control.- 9.1. Chemotherapy.- 9.2. Malaria Control.- 9.3. Vaccines.- 10. Unresolved Problems.- 11. References.- 12. Suggested Reading.- 25 Nasopharyngeal Carcinoma.- 1. Introduction.- 2. Historical Background.- 3. Methodology Involved in Epidemiological and Virological Studies.- 3.1. Sources of Mortality Data.- 3.2. Sources of Morbidity (Incidence) Data.- 3.3. Sources of Relative-Frequency Data.- 3.4. Serological Surveys.- 3.5. Sociological Surveys.- 3.6. Laboratory Diagnosis.- 4. Biological Characteristics of Epstein-Barr Virus in Its Relationship with Nasopharyngeal Carcinoma.- 5. Descriptive Epidemiology.- 5.1. Incidence, Frequency, and Geographic Distribution.- 5.2. Epidemic Behavior.- 5.3. Sex and Age.- 5.4. Occupation.- 5.5. Change of Risk on Migration.- 5.6. Environmental Factors.- 5.7. Genetic Factors.- 5.8. Epidemiological Behavior of Epstein-Barr Virus.- 6. Mechanism of Transmission.- 7. Pathogenesis.- 8. Patterns of Host Response.- 8.1. Clinical Course of Nasopharyngeal Carcinoma.- 8.2. Clinical Types of Disease.- 9. Control and Prevention.- 10. Unresolved Problems and Projects for the Future.- 10.1 Role of Epstein-Barr Virus in the Management and Control of Nasopharyneal Carcinoma.- 10.2. Chemical’ and Environmental Factors in the Causation of Nasopharyngeal Carcinoma.- 10.3. Genetic Markers and Nasopharyngeal Carcinoma.- 10.4. Conclusion.- 11. References.- 12. Suggested Reading.- 26 Cervical Cancer.- 1.Introduction.- 2. Historical Background.- 3. Methodology.- 3.1. Mortality and Morbidity of Cervical Neoplasia.- 3.2. Studies Relating Herpes Simplex Virus to Cervical Cancer.- 4. Biology of the Cancer and the Virus.- 4.1. Cervical Cancer.- 4.2. Herpes Simplex Viruses.- 5. Descriptive Epidemiology.- 5.1. Incidence and Mortality Data.- 5.2. Lifetime Risk.- 5.3. Age.- 5.4. Geographic Distribution.- 5.5. Socioeconomic Status.- 5.6. Ethnic or Religious Origin.- 5.7. Other Variables.- 6. Mechanisms and Routes of Transmission.- 7. Pathogenesis and Immunity.- 7.1. Pathogenesis.- 7.2. Immunity.- 8. Patterns of Host Response.- 8.1. Clinical and Pathological Features.- 8.2. Serological Features.- 9. Therapy and Control.- 10. Unresolved Problems.- 10.1. Control of Cervical Cancer with Available Knowledge.- 10.2. Establishing a Causal Role of Herpes Simplex Virus in Human Carcinogenesis.- 11. References.- 12. Suggested Reading.- 27 Chronic Neurological Diseases: Subacute SclerosingPanencephalitis, Progressive Multifocal Leukoencephalopathy, Kuru, Creutzfeldt-Jakob Disease.- 1. Introduction.- 2. Subacute Sclerosing Panencephalitis.- 2.1. Introduction.- 2.2. Historical Background.- 2.3. Methodology.- 2.4. Biological Characteristics of the Virus.- 2.5. Descriptive Epidemiology.- 2.6. Pathogenesis and Immunity.- 2.7. Patterns of Host Response.- 2.8. Control and Prevention.- 2.9. Unresolved Problems.- 3. Progressive Multifocal Leukoencephalopathy.- 3.1. Introduction and Historical Background.- 3.2. Methodology.- 3.3. Biological Characteristics of the Virus.- 3.4. Descriptive Epidemiology.- 3.5. Pathogenesis and Immunity.- 3.6. Patterns of Host Response.- 3.7. Unresolved Problems.- 4. Kuru.- 4.1. Introduction.- 4.2. Historical Background.- 4.3. Methodology.- 4.4. Biological Characteristics of the Virus.- 4.5. Descriptive Epidemiology.- 4.6. Mechanisms and Routes of Transmission.- 4.7. Pathogenesis and Immunity.- 4.8. Patterns of Host Response.- 4.9. Control and Prevention.- 4.10. Unresolved Problems.- 5. Creutzfeldt-Jacob Disease.- 5.1. Introduction.- 5.2. Historical Background.- 5.3. Methodology.- 5.4. Biological Characteristics of the Virus.- 5.5. Descriptive Epidemiology.- 5.6. Mechanisms and Routes of Transmission.- 5.7. Pathogenesis and Immunity.- 5.8. Patterns of Host Response.- 5.9. Control and Prevention.- 5.10. Unresolved Problems.- 6. Summary and Comparison.- 7. Unresolved Problems.- 8. References.- 9. Suggested Reading.